Comparison
Branded vs. compounded GLP-1s: which is right for you?
By the TreatmentMD editorial team
Key takeaways
- Both come as FDA-approved brands and as compounded versions from state-licensed pharmacies, typically at a lower monthly cost.1U.S. Food and Drug AdministrationSourceFDA. Compounding and the FDA: Questions and Answers. Content current as of September 16, 2025.Open the source All sources
- Brand-name cash prices now start at $149 a month, and insurance or Medicare can bring them lower still.2Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 7, 2026.Open the source All sources3Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 7, 2026.Open the source All sources
- Either way, you'll need a prescription from a licensed clinician, who'll help you choose.1U.S. Food and Drug AdministrationSourceFDA. Compounding and the FDA: Questions and Answers. Content current as of September 16, 2025.Open the source All sources
By the TreatmentMD editorial team
If you've shopped around for a GLP-1, you've probably seen two kinds: brand names like Wegovy® and Zepbound®, and compounded versions, often for less.
So which is right for you? It depends on your coverage, your budget and what you'd like, and you don't have to work it out alone. Here's a friendly side-by-side to get you started.
01The short answer
What's the difference between branded and compounded GLP-1s?
Brand-name GLP-1s come from the companies that developed them, Novo Nordisk and Eli Lilly. The FDA approved each one after large studies.4U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy® (injection and tablets), Zepbound® and Foundayo™: Indications and Usage; Dosage and Administration; Clinical Studies; How Supplied.All sources
Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies, for an individual patient's prescription.1U.S. Food and Drug AdministrationSourceFDA. Compounding and the FDA: Questions and Answers. Content current as of September 16, 2025.Open the source All sources
Compounded medicines don't go through FDA approval, because the law treats pharmacy compounding differently.1U.S. Food and Drug AdministrationSourceFDA. Compounding and the FDA: Questions and Answers. Content current as of September 16, 2025.Open the source All sources
You might hear them called generic, but they're not. A generic is FDA approved, and there's no U.S. generic semaglutide or tirzepatide on sale yet.5U.S. Food and Drug AdministrationSourceFDA. FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs. June 15, 2026.Open the source All sources6Stanford MedicineSourceWilliams S. What compounded GLP-1s mean for patient safety. Stanford Medicine, July 16, 2026.Open the source All sources
| Brand-name | Compounded | |
|---|---|---|
| Made by | Novo Nordisk or Eli Lilly | A licensed compounding pharmacy, for your prescription |
| Usually comes as | A prefilled pen, a daily pill or a vial | A vial you measure with a syringe7U.S. Food and Drug AdministrationSourceFDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024.Open the source All sources |
| Starting cash price | From $149 a month2Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 7, 2026.Open the source All sources | From $49 a month at the programs we rank |
| Covered by insurance | Sometimes8Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources | Almost never9Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0251: Compounded Medications. Effective December 15, 2025.Open the source All sources |
| Medicare's GLP-1 Bridge | Some, for $50 a month3Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 7, 2026.Open the source All sources | Not covered3Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 7, 2026.Open the source All sources |
02Cost
How do the prices compare?
Brand-name prices have come down a lot, and the pills are now the lowest-priced brand-name option. Here's what you'd pay in cash:
| Medicine | Cash price a month |
|---|---|
| Wegovy® pill | $149 to $299, by dose2Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 7, 2026.Open the source All sources |
| Foundayo™ | $149 to $299, by dose10Eli Lilly and CompanySourceLillyDirect. Foundayo™ (orforglipron) self-pay prices. Checked October 7, 2026.Open the source All sources |
| Wegovy® shot | $199 for your first two months, then $3492Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 7, 2026.Open the source All sources |
| Zepbound® | $299 to $449, by dose, when you refill on time11Eli Lilly and CompanySourceLillyDirect. Zepbound® (tirzepatide) self-pay prices. Checked October 7, 2026.Open the source All sources |
| Compounded semaglutide | From $49 at the programs we rank |
| Compounded tirzepatide | From $89 at the programs we rank |
At the programs we rank, the compounded price usually includes your clinician too, and several keep one price at every dose. We checked in early October 2026.
If you get brand-name medicine through an online program, there's usually a membership fee on top of the maker's price.
So the gap is smaller than it used to be, especially at starting doses. A handy tip: price out the dose you'll likely stay on, not just your first month.
03Insurance
Does insurance cover either one?
Sometimes, for brand-name medication, and usually only after a prior authorization. Compounded medication is almost never covered.8Novo NordiskSourceNovoCare. Check your coverage for Wegovy®. Checked October 6, 2026.Open the source All sources9Cigna HealthcareSourceCigna Healthcare. Drug Coverage Policy IP0251: Compounded Medications. Effective December 15, 2025.Open the source All sources
If your plan covers it, the maker's savings card can lower your share to as little as $25 a month.12Novo NordiskSourceNovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026.Open the source All sources13Eli Lilly and CompanySourceLilly. Zepbound® savings and insurance options. Checked October 6, 2026.Open the source All sources
With Medicare, the GLP-1 Bridge covers the Wegovy® shot and pill, the Zepbound® KwikPen and Foundayo™. It's $50 a month through 2027, for people who qualify.3Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 7, 2026.Open the source All sources
Either way, you can usually pay with an HSA or FSA.14Internal Revenue ServiceSourceIRS. Publication 502 (2025), Medical and Dental Expenses.Open the source All sources Our insurance article explains how to check your plan.
04Results
Where do the results come from?
The weight-loss results you see quoted come from big studies of the brand-name medicines.4U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy® (injection and tablets), Zepbound® and Foundayo™: Indications and Usage; Dosage and Administration; Clinical Studies; How Supplied.All sources
Whichever medicine you take, what counts is how you're doing. A good program's clinician checks in as your dose goes up, and helps if anything feels off.
05Staying safe
How do you stay safe with either one?
With brand-name medicine, the pen or pill comes ready to go, at fixed doses.4U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy® (injection and tablets), Zepbound® and Foundayo™: Indications and Usage; Dosage and Administration; Clinical Studies; How Supplied.All sources
With compounded medicine, the pharmacy matters. The safest route is a licensed clinician who knows your health history and a licensed U.S. pharmacy you can look up.15U.S. Food and Drug AdministrationSourceFDA. BeSafeRx: Locate a State-Licensed Online Pharmacy.Open the source All sources
It's worth asking your program which pharmacy makes yours. Then you can check its license with your state board in a minute or two.15U.S. Food and Drug AdministrationSourceFDA. BeSafeRx: Locate a State-Licensed Online Pharmacy.Open the source All sources
Compounded doses are often measured in units on a syringe. Ask your clinician or pharmacist to show you exactly how much to draw.7U.S. Food and Drug AdministrationSourceFDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024.Open the source All sources
With a vial, a few easy habits help:
Keep it in the fridge
If a delivery arrives warm, check with the pharmacy before you use it.16U.S. Food and Drug AdministrationSourceFDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Content current as of October 1, 2026.Open the source All sources
Start a fresh vial after 28 days
Even if there's some left, once it's been open that long.16U.S. Food and Drug AdministrationSourceFDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Content current as of October 1, 2026.Open the source All sources
Use a new needle each time
A fresh, sterile needle and syringe for every dose.16U.S. Food and Drug AdministrationSourceFDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Content current as of October 1, 2026.Open the source All sources
Our guide to compounded GLP-1s has more on how it all works.
06Availability
Can you still get both?
Yes. The brand-name medicines are off the FDA's shortage list.17U.S. Food and Drug AdministrationSourceFDA. Drug Shortages database: semaglutide, tirzepatide and orforglipron. Checked October 7, 2026.Open the source All sources The makers sell them directly, through NovoCare and LillyDirect, as well as at regular pharmacies.2Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 7, 2026.Open the source All sources11Eli Lilly and CompanySourceLillyDirect. Zepbound® (tirzepatide) self-pay prices. Checked October 7, 2026.Open the source All sources Once you have a prescription, you can have it delivered or pick it up nearby.
Compounded versions remain available through state-licensed (503A) pharmacies, prepared for an individual patient with a medical need the standard product doesn't meet.18U.S. Food and Drug AdministrationSourceFDA. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Updated April 1, 2026.Open the source All sources
A lower price on its own doesn't count, so it's always your clinician's call.19U.S. Food and Drug AdministrationSourceFDA. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry. January 2018.Open the source All sources
You'll usually get a compounded version through an online program, which connects you with a clinician and ships from a partner pharmacy. Most of the programs we rank offer compounded semaglutide and tirzepatide, and some offer brand-name medicine too.
07Choosing
Which is right for you?
It depends on your coverage, your budget and what you'd like. Here's how it often shakes out:
Your insurance covers it
Brand-name may cost you the least, especially with a savings card or Medicare's Bridge.12Novo NordiskSourceNovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026.Open the source All sources3Centers for Medicare and Medicaid ServicesSourceMedicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 7, 2026.Open the source All sources
You're paying cash
Compounded usually costs less, and several programs keep one price at every dose. The brand-name pills start at $149 a month.2Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 7, 2026.Open the source All sources
You'd like a pen or a pill
Brand-name pens come prefilled, so there's nothing to draw up, and the brand-name pills are daily tablets.4U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy® (injection and tablets), Zepbound® and Foundayo™: Indications and Usage; Dosage and Administration; Clinical Studies; How Supplied.All sources
You're still not sure
That's what your clinician is for. They'll weigh your health, budget and preferences with you.
Good questions to bring to your clinician: Which suits my budget and coverage? If it's compounded, which pharmacy makes it? How will my dose be measured?
Whichever you choose, look for a program with a real clinician, a licensed pharmacy you can look up, clear dosing help and clear pricing.
08Switching
Can you switch between them?
Yes, with a new prescription from your clinician, and lots of people do. In a 2026 survey, over a third of people on a compounded version had switched from a brand, often over cost or coverage.20GallupSourceGallup. In U.S., GLP-1 usage reaches new high. July 7, 2026.Open the source All sources
The brand-name labels don't cover switching from a compounded version. And compounded doses are often measured in units that depend on the vial's strength, so your clinician will choose your new dose.4U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy® (injection and tablets), Zepbound® and Foundayo™: Indications and Usage; Dosage and Administration; Clinical Studies; How Supplied.All sources7U.S. Food and Drug AdministrationSourceFDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024.Open the source All sources
It helps to bring your vial's label, or your dose in milligrams, to that conversation.
You'll switch from one to the other rather than taking both, as the labels advise against combining GLP-1 medicines.4U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy® (injection and tablets), Zepbound® and Foundayo™: Indications and Usage; Dosage and Administration; Clinical Studies; How Supplied.All sources
Frequently asked questions.
Is the Wegovy® pill cheaper than compounded semaglutide?
Not usually, but the gap is smaller than you might think.
The Wegovy® pill starts at $149 a month from its maker, and the price rises with the dose.2Novo NordiskSourceNovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 7, 2026.Open the source All sources
Compounded semaglutide starts at $49 a month at the programs we rank, usually as a weekly shot.
Some programs offer compounded tablets too, which are a different product from the Wegovy® pill.
Is compounded semaglutide the same as Wegovy®?
No. A licensed pharmacy prepares it for your prescription, so it isn't Wegovy®, and its strength or form can differ.
Your clinician sets your dose.1U.S. Food and Drug AdministrationSourceFDA. Compounding and the FDA: Questions and Answers. Content current as of September 16, 2025.Open the source All sources7U.S. Food and Drug AdministrationSourceFDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024.Open the source All sources
Why do some compounded versions include B12?
Some pharmacies add vitamin B12, which can tint the liquid pink.
It isn't in the brand-name medicines, and your clinician or pharmacist can tell you exactly what's in yours.7U.S. Food and Drug AdministrationSourceFDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024.Open the source All sources
How does Foundayo™ compare with compounded tirzepatide?
They're different medicines.
Foundayo™ is orforglipron, a daily brand-name pill from $149 a month that you can take with or without food.10Eli Lilly and CompanySourceLillyDirect. Foundayo™ (orforglipron) self-pay prices. Checked October 7, 2026.Open the source All sources4U.S. Food and Drug AdministrationSourceFDA prescribing information for Wegovy® (injection and tablets), Zepbound® and Foundayo™: Indications and Usage; Dosage and Administration; Clinical Studies; How Supplied.All sources Compounded tirzepatide is usually a weekly shot, from $89 a month at the programs we rank.
Your clinician can help you weigh them.
Can I get brand-name medicine through an online program?
Yes.
Some of the programs we rank offer brand-name medicine, usually with a membership fee on top of the maker's price.
Each of our reviews says what's included.
Will compounded GLP-1s go away?
They're still available, from state-licensed pharmacies for individual prescriptions.18U.S. Food and Drug AdministrationSourceFDA. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Updated April 1, 2026.Open the source All sources
The rules can change, so if your program ever changes your medicine, your clinician will walk you through your options.
The bottom line
Brand-name and compounded GLP-1s both have a place.
With insurance or Medicare, brand-name may cost you the least.
Paying cash, compounded often costs less.
Either way, your clinician will help you choose.
When you're ready, compare programs on our ranking to see what each one offers.
By the TreatmentMD editorial team
Medical disclaimerThis content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting any weight-loss program or medication. Individual results may vary.
Sources
- 1FDA. Compounding and the FDA: Questions and Answers. Content current as of September 16, 2025. fda.gov
- 2NovoCare. Wegovy® (semaglutide) self-pay prices. Checked October 7, 2026. novocare.com
- 3Medicare.gov. Weight loss drugs: the Medicare GLP-1 Bridge. Checked October 7, 2026. medicare.gov
- 4FDA prescribing information for Wegovy® (injection and tablets), Zepbound® and Foundayo™: Indications and Usage; Dosage and Administration; Clinical Studies; How Supplied.
- 5FDA. FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs. June 15, 2026. fda.gov
- 6Williams S. What compounded GLP-1s mean for patient safety. Stanford Medicine, July 16, 2026. stanford.edu
- 7FDA. FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products. July 26, 2024. fda.gov
- 8NovoCare. Check your coverage for Wegovy®. Checked October 6, 2026. novocare.com
- 9Cigna Healthcare. Drug Coverage Policy IP0251: Compounded Medications. Effective December 15, 2025. cigna.com
- 10LillyDirect. Foundayo™ (orforglipron) self-pay prices. Checked October 7, 2026. lilly.com
- 11LillyDirect. Zepbound® (tirzepatide) self-pay prices. Checked October 7, 2026. lilly.com
- 12NovoCare. Wegovy® savings offer terms and conditions. Checked October 6, 2026. novocare.com
- 13Lilly. Zepbound® savings and insurance options. Checked October 6, 2026. lilly.com
- 14IRS. Publication 502 (2025), Medical and Dental Expenses. irs.gov
- 15FDA. BeSafeRx: Locate a State-Licensed Online Pharmacy. fda.gov
- 16FDA. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss. Content current as of October 1, 2026. fda.gov
- 17FDA. Drug Shortages database: semaglutide, tirzepatide and orforglipron. Checked October 7, 2026. fda.gov
- 18FDA. FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. Updated April 1, 2026. fda.gov
- 19FDA. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry. January 2018. fda.gov
- 20Gallup. In U.S., GLP-1 usage reaches new high. July 7, 2026. gallup.com
Product information
- Zepbound® (tirzepatide) is a prescription-only injectable medication FDA-approved for chronic weight management in adults with obesity, or adults with overweight who have at least one weight-related medical condition. It is also approved for the treatment of moderate to severe obstructive sleep apnea in adults with obesity, and should be used in combination with a reduced-calorie diet and increased physical activity.
- Ozempic® (semaglutide) is a prescription-only injectable medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes. It is not FDA-approved for weight loss; however, weight reduction has been observed in some individuals with type 2 diabetes using the medication.
- Mounjaro® (tirzepatide) is a prescription-only injectable medication FDA-approved for the treatment of type 2 diabetes. It is not FDA-approved for weight loss; however, weight reduction has been observed in some individuals using the medication.
- Wegovy® (semaglutide) is a prescription-only injectable medication FDA-approved for chronic weight management in adults with obesity, or adults with at least one weight-related medical condition, when used alongside a reduced-calorie diet and increased physical activity.
- All medications require a medical evaluation and prescription from a licensed healthcare provider. Individual results may vary.
Important safety information
- Compounded semaglutide and tirzepatide are prepared by state-licensed pharmacies and are not FDA approved. The FDA does not review their safety, effectiveness or quality, and clinical trial results for brand-name drugs do not carry over to them.
- Semaglutide and tirzepatide carry a boxed warning for a risk of thyroid C-cell tumors, based on animal studies, and are not for anyone with a personal or family history of medullary thyroid carcinoma (MTC) or MEN2, or who is pregnant. Other warnings include pancreatitis, gallbladder problems, and a higher risk of low blood sugar when combined with insulin or a sulfonylurea. The most common side effects are digestive, such as nausea, vomiting, diarrhea and constipation.
- This is a high-level summary, not a complete list. A licensed clinician will review your health history to decide whether a GLP-1 medication is right for you.
